AlphAIAlphAI — Financial news for AI agents
investing.comOCT 62 min read$NEOG

Neogen stock up 8% on better-than-expected Q1 results, guidance

Neogen (NASDAQ:NEOG) reported Q1 adjusted EPS of $0.08, beating estimates by $0.03, with revenue of $222.8M, up 6.5% YoY. The company raised its FY2027 revenue guidance to $885-890M. Shares rose 8% in after-hours trading, reversing an 8.07% drop during regular trading.

Original reporting
investing.com
Published Oct 6, 2026, 8:09 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 8:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$NEOG
Bullish
high confidence
Mentioned
$NEOG
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$NEOGBullishHigh
01

Why it matters

The earnings beat and raised guidance suggest operational improvements and could attract growth‑oriented investors.

02

Market read

The earnings surprise and guidance lift are the primary drivers of the stock's 8% after‑hours move.

03

What to watch

Potential headwinds from foreign currency volatility and upcoming competitive pricing pressures.

Relevance 8/10Novelty 8/10Timing: after‑hours today

Background

Neogen is a provider of food safety and animal health testing products. The Q1 results were released on Oct 6, 2026.

Company-level read

Ticker impact

$NEOGBullishHigh confidence
Context

Neogen reported Q1 earnings that beat estimates and raised full-year guidance, sending the stock up 8% after hours.

Expected impact

upward pressure as investors price in stronger revenue and EBITDA outlook

Evidence & confidence

Adjusted EPS of $0.08 vs $0.05 consensus and revenue beat $222.8M vs $204.7M, plus raised FY revenue and EBITDA guidance, triggered an 8% after‑hours rally.

Market effects

Sector

Food safety and animal health segments may see broader optimism as Neogen's beat suggests strong demand.

Regional

U.S. biotech and specialty chemicals markets could see modest uplift.

Global

Limited to investors focused on niche safety solutions; no major macro effect.

Counterpoint

What could challenge this read

The net loss of $11.9M and a modest EPS beat may not sustain the rally if future quarters revert.

Key entities

  • Executive
    Mike Nassif

    President and CEO of Neogen, quoted on operational progress.

Read at source← All news

Also covered by

2 outlets

Related articles

OCT 6
$NEOGMedAI 8/10

What Neogen (NEOG) Said on Its Q1 Earnings Call

Neogen (NEOG) reported Q1 adjusted EBITDA of $41.6M, up 170 bps YoY. Adjusted net income was $17.5M, EPS $0.08. Free cash flow improved by $18M. Debt stood at $774M, cash at $172M. The company raised fiscal 2027 revenue guidance to $885M-$890M and adjusted EBITDA to $181M-$183M. It expects margin improvements post-Petrifilm transition and announced a collaboration with Hinalea. The genomics sale is under regulatory review, with proceeds earmarked for debt reduction.

finance.yahoo.com2 min
OCT 6
$NEOGMedAI 8/10

Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics

Neogen (NEOG) reported Q1 revenues across various segments, generally meeting or exceeding estimates. Food Safety revenues grew 7.3% YoY to $163.2M, while Animal Safety revenues increased 4.3% YoY to $59.6M. Some segments saw significant changes, such as Animal Safety Genomics Services, up 211.4% YoY, and Food Safety Genomics Services, down 59.6% YoY.

finance.yahoo.com2 min
OCT 6
$NEOGMed

Neogen’s (NASDAQ:NEOG) Q3 CY2026: Strong Sales, Stock Soars

Neogen (NEOG) reported Q3 CY2026 revenue of $222.8M, beating estimates by 7% and growing 6.5% YoY. Adjusted EPS of $0.08 beat estimates by 50%. The company raised full-year revenue guidance to $887.5M and EBITDA guidance to $182M, both above analyst estimates. Operating margin improved to -0.8% from -7.7% YoY, and free cash flow turned positive at $4.7M.

finance.yahoo.com2 min
OCT 6
$PENGHighAI 8/10

After-Hours Movers: PENG, STZ, NEOG

Penguin Solutions (PENG) rose 3% after reporting strong Q4 results and upbeat FY2027 guidance. Constellation Brands (STZ) fell 5% despite Q2 beat, citing lower FY2027 EPS guidance. Neogen (NEOG) surged 8% on Q1 beat and raised FY2027 revenue outlook. PENG: $1.00 adj. EPS, $567M revenue; STZ: $3.74 EPS, $2.63B revenue; NEOG: $0.08 EPS, $222.8M revenue.

investing.com2 min
OCT 6
$NEOGHighAI 8/10

Neogen: Fiscal Q1 Earnings Snapshot

Neogen Corp. (NEOG) reported a fiscal Q1 loss of $11.9 million, or 5 cents per share, but adjusted earnings of 8 cents per share, beating analyst estimates. Revenue was $222.8 million, exceeding expectations. The company forecasts full-year revenue between $885M and $890M.

finance.yahoo.com2 min